Murali is the inventor of the cardiac leaflet enhancer (CARLEN) technology, developing it from an idea, through de-risking it to its current advanced preclinical stage. In 2020, he spun the technology off into Nyra Medical, and developed a team to advance it through regulatory approvals for early feasibility trials in human patients.He holds a PhD in Bioengineering and a MS in Mechanical Engineering from Georgia Institute of Technology, USA and a BS in Mechanical Engineering from Osmania University, India. He is a graduate of the Kauffman foundation techventure program that prepares biomedical technology innovators to develop their products into commercial businesses.
Murali is the inventor of the cardiac leaflet enhancer (CARLEN) technology, developing it from an idea, through de-risking it to its current advanced preclinical stage. In 2020, he spun the technology off into Nyra Medical, and developed a team to advance it through regulatory approvals for early feasibility trials in human patients.He holds a PhD in Bioengineering and a MS in Mechanical Engineering from Georgia Institute of Technology, USA and a BS in Mechanical Engineering from Osmania University, India. He is a graduate of the Kauffman foundation techventure program that prepares biomedical technology innovators to develop their products into commercial businesses.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy